Metabolon
Metabolon is a leading metabolomics company with over 20 years of experience, completing over 10,000 projects and publishing more than 3,000 papers. The company offers a wide range of targeted and untargeted metabolomics panels and assays, serving various markets and therapeutic areas.
Company History
Metabolon has over 20 years of experience in the field of metabolomics, during which it has cemented its position as a leading company in the industry. With a rich history marked by significant milestones, the company has completed over 10,000 projects and produced more than 3,000 publications. By continuously advancing its technology and expanding its knowledge base, Metabolon has become a pivotal player in various sectors including academic research, precision medicine, and more.
Products and Technologies
Metabolon offers a wide range of targeted metabolomics panels and assays that cover more than 1,000 metabolites and lipids. Some of the key offerings include the Global Discovery Panel, Biological Stress Discovery Panel, Kidney Function Discovery Panel, and Liver Fibrosis Discovery Panel. Additionally, the company provides specialized panels such as the Complex Lipids Targeted Panel, Bile Acids Targeted Panel, Short Chain Fatty Acids Targeted Panel, and the Diabetes Research Markers Targeted Panel. The company's proprietary library, built over two decades, boasts over 5,400 entries, making it the largest Level 1 library in the metabolomics industry.
Services
Metabolon provides a comprehensive suite of services to its clients. These include custom method development, sample matrix validation, and offering single analyte assays for specific analyte studies. The company also leverages its bioinformatics platform for visualizing complex datasets and employs machine learning and artificial intelligence for in-depth analysis. Additionally, Metabolon collaborates with various companies to validate sample collection devices for ambient-temperature storage and transport.
Research and Partnerships
Metabolon is actively involved in a number of strategic partnerships and research collaborations. Notably, the company has partnered with Cardiff University’s Division of Psychological Medicine and Clinical Neuroscience for multiple sclerosis research. These collaborations span diverse fields such as cardiovascular disease, diabetes, oncology, and women's health. The strategic partnership program enables Metabolon to extend its impact and drive innovation within the metabolomics landscape.
Market Applications
Metabolon serves a multitude of markets including academic research, environmental and agricultural sectors, biopharma, food and nutritional sciences, cosmeceutical research, and veterinary and animal health research. The company’s applications in therapeutic areas encompass cardiovascular disease, diabetes, inflammation, neuroscience, oncology, renal and urological disorders, respiratory disorders, and women's health. These extensive applications illustrate the adaptability and significance of Metabolon’s metabolomics technologies across various industries.
Educational Initiatives
Metabolon places a strong emphasis on education and outreach, offering webinars and virtual events to disseminate knowledge and engage with the scientific community. The company provides a comprehensive resource library that includes publications, case studies, and webinars, making valuable information readily accessible to researchers and practitioners alike. These initiatives underscore Metabolon’s commitment to driving forward the field of metabolomics through shared learning and community engagement.